The Pediatric Oncology Branch treats leukemia and lymphoma patients with multiple relapses or those that have not responded to standard therapy. For those children with leukemia or lymphoma for whom effective treatment no longer exists, the Pediatric Oncology Branch has trials of new, experimental anti-cancer drugs and one non-myeloablative bone marrow transplantation protocol.
The Pediatric Oncology Branch has also focused research efforts on the treatment of meningeal leukemia (leukemia which has spread to the meninges or covering of the brain and spinal cord). An experimental protocol is available for children who have relapsed in the meninges.

The Pediatric Oncology Branch has also focused research efforts on the treatment of meningeal leukemia (leukemia which has spread to the meninges or covering of the brain and spinal cord). A number of protocols utilizing anti-leukemia drugs exist for children who have relapsed in meninges.

For children with relapsed ALL for whom effective treatment no longer exists, the Pediatric Oncology Branch has Phase 1 clinical trials of a spectrum of new, experimental anti-cancer drugs. Additional information on Phase 1 trials can be obtained from the Pharmacology and Experimental Therapeutics Section.

Leukemia Protocols

Last Updated: March 10, 2003

NCI Home Page|| NIH Home Page

© 2002-2003, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute